Skip to main content
. 2022 Mar 9:NEJMoa2200797. doi: 10.1056/NEJMoa2200797

Figure 3. Estimated Cumulative Incidence of Symptomatic Delta Variant Infection in the Matched Booster (BNT162b2 Vaccine) and Nonbooster Cohorts.

Figure 3